Sarcoidosis is caused by tiny granulomas forming most commonly in the lungs or lymph nodes and eyes. Doctors believe it is the result of the immune system trying to fight off pathogens that were likely inhaled, but scientists are now trying to pin it down to provide better diagnostic tools and ultimately better treatments for patients.
In the study, a certain marker molecule (cell surface marker 6-sulfo LacNAc aka “slan”) shows a better determination of other monocyte subgroups. They are hoping that this discovery will also lead to a better understanding of other related rare diseases.
For more than 90% of patients with sarcoidosis, the disease manifests itself in the lungs causing shortness of breath, leg swelling, and heart palpitations. Treatment varies according to patient needs, but to date, there is no cure.
